Home >> Signaling Pathways >> GPCR/G protein

GPCR/G protein

Products for  GPCR/G protein

  1. Cat.No. Product Name Information
  2. GC31295 Balovaptan (RG7314) Balovaptan (RG7314) (RG7314) is an orally available, selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors, and is used for the research of autism. Balovaptan (RG7314)  Chemical Structure
  3. GC15971 BAM (8-22) selective agonist for the sensory neuron specific receptor BAM (8-22)  Chemical Structure
  4. GC13577 Bambuterol long acting beta-adrenoceptor agonist Bambuterol  Chemical Structure
  5. GC42896 Bambuterol (hydrochloride) Bambuterol is a prodrug for terbutaline, a long-acting β-adrenoceptor agonist (Ki = 15.4 μM for human β2-adrenergic receptor). Bambuterol (hydrochloride)  Chemical Structure
  6. GC63433 Bambuterol-d9 hydrochloride Bambuterol-d9 hydrochloride  Chemical Structure
  7. GC15926 BAN ORL 24 A nociceptin receptor antagonist BAN ORL 24  Chemical Structure
  8. GN10507 Baohuoside I

    Baohuoside I, a flavonoid isolated from Epimedium koreanum Nakai, acts as an inhibitor of CXCR4, downregulates CXCR4 expression, induces apoptosis and shows anti-tumor activity.

    Baohuoside I  Chemical Structure
  9. GC40637 BAR501 BAR501 is a selective agonist of the G protein-coupled bile acid-activated receptor (GP-BAR1; EC50 = 1 μM) that lacks activity at the farnesoid X receptor (FXR). BAR501  Chemical Structure
  10. GC30565 BAR502 A dual agonist of GP-BAR1 and FXR BAR502  Chemical Structure
  11. GC31690 Batefenterol (GSK961081) Batefenterol (GSK961081) (GSK961081;TD-5959) is a novel muscarinic receptor antagonist and β2-adrenoceptor agonist; displays high affinity for hM2, hM3 muscarinic and hβ2-adrenoceptor with Ki values of 1.4, 1.3 and 3.7 nM, respectively. Batefenterol (GSK961081)  Chemical Structure
  12. GC61778 BAY 38-7271 BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively. BAY 38-7271  Chemical Structure
  13. GC13666 Bay 55-9837 Selective VPAC2 receptor agonist Bay 55-9837  Chemical Structure
  14. GC19060 Bay 59-3074 Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Bay 59-3074  Chemical Structure
  15. GC18114 BAY 60-6583 Potent A2B receptor agonist BAY 60-6583  Chemical Structure
  16. GC61581 BAY 73-1449 BAY 73-1449 is a selective antagonist of prostacyclin receptor (IP), with high potency (IC50 of less than 0.1 nM) in cAMP assays in Human HEL cells and rat DRG. BAY 73-1449  Chemical Structure
  17. GC15640 BAY u3405 BAY u3405 is a selective thromboxane A2 (TxA2, IC50=14 nM) antagonist, which also antagonizes CRTH2 (IC50=113 nM) by inhibiting PGD2 binding. BAY u3405  Chemical Structure
  18. GC64958 BAY-1316957 BAY-1316957 is a potent, selective and orally active prostaglandin E2 receptor subtype 4 (EP4-R) antagonist with an IC50 of 15.3 nM for human EP4-R. BAY-1316957  Chemical Structure
  19. GC33186 BAY-293 An inhibitor of the K-Ras-SOS1 protein-protein interaction BAY-293  Chemical Structure
  20. GC19502 BAY-545

    BAY-545 is a potent and selective A2B adenosine receptor antagonist

    BAY-545   Chemical Structure
  21. GC10266 BAY-u 9773 Antagonist of CysLT1/CysLT2 receptors BAY-u 9773  Chemical Structure
  22. GC12232 BAY-X 1005 BAY-X 1005 (BAY X 1005; DG-031) is an orally active and selective 5-lipoxygenase activating protein (FLAP) inhibitor. BAY-X 1005  Chemical Structure
  23. GC13020 BayCysLT2 CysLT2 receptor antagonist BayCysLT2  Chemical Structure
  24. GC16595 BD 1008 dihydrobromide δ1-receptor antagonist,potent and selective BD 1008 dihydrobromide  Chemical Structure
  25. GC15374 BD 1047 dihydrobromide σ1 receptor antagonist BD 1047 dihydrobromide  Chemical Structure
  26. GC15838 BD 1063 dihydrochloride BD 1063 dihydrochloride is a potent and selective sigma 1 receptor antagonist. BD 1063 dihydrochloride  Chemical Structure
  27. GC33340 BDP9066 BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively. BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation. BDP9066  Chemical Structure
  28. GC33856 Beclometasone (Beclomethasone) Beclometasone (Beclomethasone) (Beclomethasone) is a prototype glucocorticoid receptor agonist. Beclometasone (Beclomethasone)  Chemical Structure
  29. GC35485 Beclometasone dipropionate Beclometasone dipropionate  Chemical Structure
  30. GC61536 Beclomethasone 17-propionate Beclomethasone 17-propionate (Beclomethasone-17-monopropionate), an active metabolite of Beclomethasone dipropionate, is a glucocorticoid receptor (GR) agonist. Beclomethasone 17-propionate  Chemical Structure
  31. GC17465 Beclomethasone dipropionate Corticosteroid used for asthma and rhinitis Beclomethasone dipropionate  Chemical Structure
  32. GC33724 Befetupitant (Ro67-5930) Befetupitant (Ro67-5930) is a high-affinity, nonpeptide, competitive tachykinin 1 receptor (NK1R) antagonist. Befetupitant (Ro67-5930)  Chemical Structure
  33. GC31113 Befiradol (NLX-112) Befiradol (NLX-112) (NLX-112) is a selective 5-HT1A receptor agonist. Befiradol (NLX-112)  Chemical Structure
  34. GC34304 Befiradol hydrochloride (NLX-112 (hydrochloride)) Befiradol hydrochloride (NLX-112 (hydrochloride))  Chemical Structure
  35. GC46913 Benazepril-d5 (hydrochloride) An internal standard for the quantification of benazapril Benazepril-d5 (hydrochloride)  Chemical Structure
  36. GC46915 Bendiocarb A broad-spectrum carbamate insecticide Bendiocarb  Chemical Structure
  37. GC31872 Benorilate (Benoral) Benorylate (Salipran) is the esterification product of paracetamol and acetylsalicylic acid. Benorilate (Benoral)  Chemical Structure
  38. GC65252 Benoxathian hydrochloride Benoxathian hydrochloride is a potent α1 adrenoceptor antagonist, can be used for researching anorexia. Benoxathian hydrochloride  Chemical Structure
  39. GC35492 Benzamide Derivative 1 Benzamide Derivative 1 is a benzamide derivative from patent EP0213775A1, compound 18. Benzamide Derivative 1  Chemical Structure
  40. GC30925 Benzetimide hydrochloride (R4929) Benzetimide hydrochloride (R4929) is a muscarinic acetylcholine receptor antagonist. Benzetimide hydrochloride (R4929)  Chemical Structure
  41. GC30474 Benzquinamide (P2647) Benzquinamide (P2647)  Chemical Structure
  42. GC16791 Benztropine mesylate Dopamine transporter (DAT) inhibitor Benztropine mesylate  Chemical Structure
  43. GC31942 Beperidium iodide (SX 810) Beperidium iodide (SX 810) shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93. Beperidium iodide (SX 810)  Chemical Structure
  44. GC38891 Beraprost sodium Beraprost sodium, a prostacyclin analog, is a stable and orally active prodrug of PGI2. Beraprost sodium  Chemical Structure
  45. GC10936 Betamethasone Glucocorticoid receptor agonist Betamethasone  Chemical Structure
  46. GC35502 Betamethasone acibutate Betamethasone acibutate, derives from Betamethasone, is an acetate ester. Betamethasone acibutate  Chemical Structure
  47. GC12122 Betamethasone Dipropionate Glucocorticoid receptor agonist Betamethasone Dipropionate  Chemical Structure
  48. GC35503 Betamethasone hydrochloride Betamethasone hydrochloride is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive activities. Betamethasone hydrochloride  Chemical Structure
  49. GC13638 Betamethasone Valerate anti-inflammatory corticosteroid Betamethasone Valerate  Chemical Structure
  50. GC14021 Betaxolol βadrenergic receptor blocker Betaxolol  Chemical Structure
  51. GC17731 Betaxolol HCl Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker that can be used for the research of hypertension and glaucoma. Betaxolol HCl  Chemical Structure
  52. GC14419 Bethanechol chloride Muscarinic receptor agonist Bethanechol chloride  Chemical Structure
  53. GC16232 BETP glucagon-like peptide 1 (GLP-1) receptor modulator BETP  Chemical Structure
  54. GC39546 Bevantolol hydrochloride A β1-AR antagonist Bevantolol hydrochloride  Chemical Structure
  55. GC42927 BGC 20-1531 (hydrochloride) BGC 20-1531 is a potent and selective antagonist of the prostaglandin E2 receptor subtype 4 (EP4) with Ki values of 11.7, >10,000, and >10,000 nM for EP4, EP2, and EP3, respectively. BGC 20-1531 (hydrochloride)  Chemical Structure
  56. GC15092 BGC 20-761 5-HT6 antagonist,selective and high affinity BGC 20-761  Chemical Structure
  57. GC62867 BGC-20-1531 free base BGC-20-1531 (PGN 1531) free base is a potent and selective prostanoid EP4 receptor antagonist, with a pKB of 7.6. BGC-20-1531 free base  Chemical Structure
  58. GC65345 BI 653048 BI 653048 is a selective and orally active nonsteroidal?glucocorticoid (GC)?agonist with an IC50 value of 55 nM. BI 653048  Chemical Structure
  59. GC38378 BI-167107 BI-167107 is a high affinity, full agonist that binds to the β2 adrenergic receptor (β2AR) with a dissociation constant Kd of 84 pM. BI-167107  Chemical Structure
  60. GC35513 BI-2852 BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity. BI-2852 is mechanistically distinct from covalent KRASG12C inhibitor (binds to switch II pocket) and binds ten-fold more strongly to active KRASG12D?versus KRASwt?(740?nM vs 7.5?μM). BI-2852 blocks GEF, GAP, and effector interactions with KRAS, leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells. BI-2852  Chemical Structure
  61. GC68760 BI-2865

    BI-2865 is a non-covalent pan-KRAS inhibitor. BI-2865 binds to KRAS WT, G12C, G12D, G12V and G13D mutants with KD values of 6.9, 4.5, 32, 26 and 4.3 nM respectively. BI-2865 inhibits the proliferation of BaF3 cells expressing KRAS G12C, G12D or G12V mutations (average IC50: approximately 140 nM).

    BI-2865  Chemical Structure
  62. GC31757 BI-671800 An antagonist of CRTH2/DP2 BI-671800  Chemical Structure
  63. GC62412 BI-6901 BI 6901 is a potent, selective CCR10 antagonist (pIC50=9.0). BI-6901  Chemical Structure
  64. GC14089 BIBO 3304 trifluoroacetate NPY Y1 receptor antagonist,highly selective BIBO 3304 trifluoroacetate  Chemical Structure
  65. GC61530 BIBO3304 TFA BIBO3304 TFA has subnanomolar affinity for both the human and the rat neuropeptide Y (NPY) Y1 receptor with IC50 values of 0.38±0.06 nM and 0.72±0.42 nM, respectively. BIBO3304 TFA  Chemical Structure
  66. GC11074 BIBP 3226 trifluoroacetate BIBP 3226 trifluoroacetate is a potent and selective neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist, with Kis of 1.1, 79, and 108 nM for rNPY Y1, hNPFF2, and rNPFF, respectively. BIBP 3226 trifluoroacetate  Chemical Structure
  67. GC48494 BIBP3226 A nonpeptide antagonist of NPY receptor Y1 BIBP3226  Chemical Structure
  68. GC19071 BIBS 39 BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist. BIBS 39  Chemical Structure
  69. GC17806 Bicifadine hydrochloride noradrenalin transporter antagonist Bicifadine hydrochloride  Chemical Structure
  70. GA20807 Big Endothelin-1 (1-38), human Big Endothelin-1 (1-38), human is the precursor of endothelin-1. Big Endothelin-1 (1-38), human  Chemical Structure
  71. GA20808 Big Endothelin-1 (1-39), porcine Big Endothelin-1 (1-39), porcine is the precursor of endothelin-1. Big Endothelin-1 (1-39), porcine  Chemical Structure
  72. GC50414 BigLEN (mouse) GPR171 agonist BigLEN (mouse)  Chemical Structure
  73. GC17424 BIIE 0246 NPY Y2 receptor antagonist BIIE 0246  Chemical Structure
  74. GC50741 BIIE 0246 hydrochloride BIIE 0246 hydrochloride  Chemical Structure
  75. GC35517 BIIL-260 hydrochloride BIIL-260 hydrochloride is a potent and long-acting orally active leukotriene B(4) receptor LTB4 antagonist, with anti-inflammatory activity. BIIL-260 hydrochloride  Chemical Structure
  76. GC15165 BIM 187 Bombesin/GRP receptor agonist BIM 187  Chemical Structure
  77. GC14279 BIM 189 Bombesin antagonist BIM 189  Chemical Structure
  78. GC17080 BIM 23042 Antagonist of neuromedin B receptor,selective BIM 23042  Chemical Structure
  79. GC14119 BIM 23052 sst5 receptor agonist BIM 23052  Chemical Structure
  80. GC16400 BIM 23056 Somatostatin receptor ligand BIM 23056  Chemical Structure
  81. GC11620 BIM 23127 Antagonist of neuromedin B receptor BIM 23127  Chemical Structure
  82. GC62381 BIM-23190 hydrochloride BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly. BIM-23190 hydrochloride  Chemical Structure
  83. GC12687 Bimatoprost prostaglandin analog Bimatoprost  Chemical Structure
  84. GC14925 BIMU 8 5-HT4 agonist BIMU 8  Chemical Structure
  85. GC12510 BINA BINA (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders. BINA  Chemical Structure
  86. GC13335 Bindarit

    Bindarit is a small molecule that is able to prevent the chronicity of inflammation

    Bindarit  Chemical Structure
  87. GC64647 Binodenoson Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson  Chemical Structure
  88. GA20847 Biotinyl-Substance P Biotinyl-Substance P is the biotin tagged Substance P. Biotinyl-Substance P  Chemical Structure
  89. GC35524 Biperiden Biperiden (KL 373) is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system. Biperiden  Chemical Structure
  90. GC10621 Biperiden HCl Biperiden (KL 373) hydrochloride is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system. Biperiden HCl  Chemical Structure
  91. GC25140 Bisoprolol Bisoprolol is a cardioselective β1-adrenergic blocking agent used for secondary prevention of myocardial infarction (MI), heart failure, angina pectoris and mild to moderate hypertension. Bisoprolol  Chemical Structure
  92. GC14818 Bisoprolol fumarate Bisoprolol fumarate is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol fumarate  Chemical Structure
  93. GC17526 BKT140 BKT140 (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ~1 nM. BKT140  Chemical Structure
  94. GC14160 Blonanserin Atypical antipsychotic Blonanserin  Chemical Structure
  95. GC14758 BM 567 dual acting antithrombogenic agent, acting as an inhibitor of thromboxane A2 (TXA2) synthase and as an antagonist of the TP receptor BM 567  Chemical Structure
  96. GC13497 BML-111 BML-111, a lipoxin A4 analog, is a lipoxin A4 receptor agonist. BML-111  Chemical Structure
  97. GC11376 BML-190 CB2 receptor ligand BML-190  Chemical Structure
  98. GC15537 BMS 182874 hydrochloride ETA antagonist BMS 182874 hydrochloride  Chemical Structure
  99. GC14881 BMS 193885 Competitive NPY Y1 receptor antagonist BMS 193885  Chemical Structure
  100. GC38496 BMS CCR2 22 BMS CCR2 22  Chemical Structure
  101. GC14317 BMS CCR2 22 CCR2 chemokine receptor antagonist BMS CCR2 22  Chemical Structure

Items 501 to 600 of 2996 total

per page
  1. 4
  2. 5
  3. 6
  4. 7
  5. 8

Set Descending Direction